As of April 16, 2025, ADMA Biologics (ADMA) has a market cap of $5.26 billion USD. According to our data, ADMA Biologics is ranked No.2477 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $5.26 B |
29.82%
|
Dec 31, 2024 | $4.05 B |
279.42%
|
Dec 29, 2023 | $1.07 B |
16.49%
|
Dec 30, 2022 | $0.92 B |
175.18%
|
Dec 31, 2021 | $0.33 B |
-27.69%
|
Dec 31, 2020 | $0.46 B |
-51.25%
|
Dec 31, 2019 | $0.95 B |
67.36%
|
Dec 31, 2018 | $0.56 B |
-25.55%
|
Dec 29, 2017 | $0.76 B |
-37.30%
|
Dec 30, 2016 | $1.21 B |
-36.56%
|
Dec 31, 2015 | $1.91 B |
-27.75%
|
Dec 31, 2014 | $2.64 B |
43.21%
|
Dec 31, 2013 | $1.84 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() CSL
CSL.AX
|
$74.79 B |
-0.212 B
|
![]() Australia
|
![]() Grifols
GRFS
|
$5.71 B |
3.909 B
|
![]() Spain
|
![]() Takeda Pharmaceutical
TAK
|
$45.76 B |
0.002 M
|
![]() Japan
|
![]() Biolife Solutions
BLFS
|
$1.07 B |
0.000 M
|
![]() USA
|
![]() Kamada
KMDA
|
$0.36 B |
-0.000 M
|
![]() Israel
|
![]() Emergent BioSolutions
EBS
|
$0.25 B |
0.000 M
|
![]() USA
|
![]() Baxter
BAX
|
$14.26 B |
0.000 M
|
![]() USA
|
![]() ADMA Biologics
ADMA
|
$5.26 B |
-0.000 M
|
![]() USA
|
Market Cap | = | ADMA Stock Price | * | ADMA Shares Outstanding |
= | $22.15 | * | 0.24 B | |
= | $5.26 B |